Charles Kinder, MD
Clinical Cardiac Electrophysiology · Berwyn, ILNPI 1346204518
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $139,098 of the $163,526 with a category attached, or 85.1%. 36 manufacturers reported payments, led by Pfizer at 48.2% of the total. Reporting peaked in 2019 at $64,621 and has fallen 97.7% since, to $1,479 in 2025. Among clinical cardiac electrophysiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 615 payments — averaging $265.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$79K
- E.r. Squibb & Sons, L.L.C.$78K
- Novartis$2K
- Boston Scientific$633
- Elutia, Inc.$517
- Preventric Diagnostics, Inc.$465
- plus $3K from 30 others
What the payments were for
- Consulting fees$1,5001%
- Speaking & faculty fees$139,09885%
- Travel & lodging$10,0026%
- Food & beverage$12,9278%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 150 | $78,842 |
| E.r. Squibb & Sons, L.L.C. | 127 | $77,998 |
| Novartis | 119 | $2,083 |
| Boston Scientific | 29 | $633 |
| Elutia, Inc. | 38 | $517 |
| Preventric Diagnostics, Inc. | 1 | $465 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 28 | $402 |
| Kestra Medical Technology Services, Inc. | 3 | $369 |
| Amgen | 19 | $318 |
| Boehringer Ingelheim | 9 | $205 |
| Johnson & Johnson | 11 | $200 |
| Merck | 10 | $182 |
| Sanofi-aventis U.S. LLC | 11 | $168 |
| AstraZeneca | 10 | $156 |
| Scpharmaceuticals Inc. | 8 | $153 |
| Novo Nordisk | 4 | $107 |
| Esperion Therapeutics, Inc. | 6 | $106 |
| Bayer | 4 | $92 |
| Lundbeck LLC | 5 | $82 |
| Inspire Medical Systems, Inc. | 3 | $70 |
| Amarin Pharma, Inc. | 3 | $56 |
| Cvrx, Inc. | 2 | $48 |
| Siemens Medical Solutions USA, Inc. | 1 | $34 |
| Philips North America LLC | 2 | $28 |
| Lilly USA, LLC | 1 | $23 |
| Biotronik Inc. | 1 | $21 |
| Altathera Pharmaceuticals LLC | 1 | $20 |
| Chiesi USA, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Atricure, Inc. | 1 | $17 |
| Medtronic | 1 | $12 |
| Itamar Medical Inc | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$151,559
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM$465
- Assure WCD$332
- VYNDAQEL$106
How this compares
$163,526 in reported general payments places this provider in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 596 | $747,941 |
| XareltoRivaroxaban | 80 | $102,865 |
| EntrestoSacubitril/Valsartan | 69 | $88,497 |
| MultaqDronedarone Hcl | 15 | $31,795 |
| SotalolSotalol Hcl | 449 | $6,498 |
| Amiodarone Hcl | 411 | $5,942 |
| Metoprolol Succinate | 330 | $4,271 |
| Flecainide Acetate | 101 | $2,887 |
| Carvedilol | 133 | $1,437 |
| Sotalol AfSotalol Hcl | 52 | $1,226 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 36 | $723 |
| Doxycycline Hyclate | 132 | $719 |
| Digoxin | 32 | $610 |
| Amlodipine Besylate | 82 | $551 |
| Losartan Potassium | 52 | $542 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $78,842 | $747,941596 claims |
| Johnson & JohnsonXarelto | $200 | $102,86580 claims |
| NovartisEntresto | $2,083 | $88,49769 claims |
| Sanofi-aventis U.S. LLCMultaq | $168 | $31,79515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Berwyn
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
- Cash CaseyElmhurst$287K
- Moeen SaleemNaperville$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.